Evaluation of Warfarin Anticoagulation at University of Gondar Comprehensive Specialized Hospital, North-West Ethiopia

References

• Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–e360. doi:10.1161/CIR.0000000000000350
   PubMed Web of Science ®Google Scholar
• Mbewu A. The burden of cardiovascular disease in sub-Saharan Africa: burden of cardiovascular disease. SA Heart J. 2009;6(1):4–10.
   Google Scholar
• Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3):338S–400S.
   Web of Science ®Google Scholar
• Wadelius M, Pirmohamed M. Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics J. 2007;7(2):99. doi:10.1038/sj.tpj.6500417
   PubMed Web of Science ®Google Scholar
• Barnes G, Ageno W, Ansell J, Kaatz S. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(6):1154–1156. doi:10.1111/jth.12969
   PubMed Web of Science ®Google Scholar
• Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6):160S–98S.
   PubMed Web of Science ®Google Scholar
• Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e44S–e88S.
   PubMed Web of Science ®Google Scholar
• Kuruvilla M, Gurk-Turner C. A review of warfarin dosing and monitoring. Proc (Bayl Univ Med Cent). 2001;14(3):305. doi:10.1080/08998280.2001.11927781
   PubMedGoogle Scholar
• Drugs.com. Warfarin drug interactions; February 2, 2021. https://www.drugs.com/drug-interactions/warfarin.html. Accessed February 18, 2021.
   Google Scholar
• Nutescu EA, Shapiro NL, Ibrahim S, West P. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Med Saf. 2006;5(3):433–451. doi:10.1517/14740338.5.3.433
   PubMed Web of Science ®Google Scholar
• Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its medication and food interactions. Arch Intern Med. 2005;165(10):1095–1106. doi:10.1001/archinte.165.10.1095
   PubMed Web of Science ®Google Scholar
• Sonuga BO, Hellenberg DA, Cupido CS, Jaeger C. Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa. Afr J Prim Health Care Fam Med. 2016;8(1):1–8. doi:10.4102/phcfm.v8i1.1032
   Google Scholar
• Teles JS, Fukuda EY, Feder D. Warfarin: pharmacological profile and medication interactions with antidepressants. Einstein (Sao Paulo). 2012;10(1):110–115. doi:10.1590/S1679-45082012000100024
   Google Scholar
• Karuri SW Quality of oral anticoagulation management among patients on follow up at Kenyatta national hospital. University of Nairobi; 2016.
   Google Scholar
• Farsad B-F, Abbasinazari M, Dabagh A, Bakshandeh H. Evaluation of Time in Therapeutic Range (TTR) in patients with non-valvular atrial fibrillation receiving treatment with Warfarin in Tehran, Iran: a cross-sectional study. J Clin Diagn Res. 2016;10(9):FC04. doi:10.7860/JCDR/2016/21955.8457
   Google Scholar
• Caldeira D, Cruz I, Morgado G, et al. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study. BMC Res Notes. 2014;7(1):891. doi:10.1186/1756-0500-7-891
   Google Scholar
• Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM. Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res. 2009;124(1):37–41. doi:10.1016/j.thromres.2008.09.016
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Pogue J, Eikelboom J, et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118(20):2029–2037. doi:10.1161/CIRCULATIONAHA.107.750000
   PubMed Web of Science ®Google Scholar
• Haas S, Ten Cate H, Accetta G, et al. Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry. PLoS One. 2016;11(10):e0164076. doi:10.1371/journal.pone.0164076
   PubMed Web of Science ®Google Scholar
• Mearns ES, White CM, Kohn CG, et al. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J. 2014;12(1):14. doi:10.1186/1477-9560-12-14
   PubMedGoogle Scholar
• Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330–1393.
   PubMed Web of Science ®Google Scholar
• McDonald KM; UCSF-Stanford E. Making health care safer a critical analysis of patient safety practices. Am J Health Syst Pharm. 1995;52:2543–2549. doi:10.1093/ajhp/52.22.2543
   Web of Science ®Google Scholar
• Khan TI, Kamali F, Kesteven P, Avery P, Wynne H. The value of education and self‐monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol. 2004;126(4):557–564. doi:10.1111/j.1365-2141.2004.05074.x
   PubMed Web of Science ®Google Scholar
• Melamed OC, Horowitz G, Elhayany A, Vinker S. Quality of anticoagulation control among patients with atrial fibrillation. Am J Manag Care. 2011;17(3):232–237.
   PubMed Web of Science ®Google Scholar
• Verhovsek M, Motlagh B, Crowther MA, et al. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review. BMC Geriatr. 2008;8(1):13. doi:10.1186/1471-2318-8-13
   PubMedGoogle Scholar
• Bhattacharyya A, Bhavnani M, Tymms DJ. Serious interaction between digoxin and warfarin. Br J Cardiol. 2002;9(6):356–357.
   Google Scholar